Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes—heart failure with ...

Eli Lilly has seen revenue and earnings soar in recent years.

CHARLOTTE — Right now, there are more than 250 generic drugs on the market that show potential for fighting cancer, even though they were developed for other diseases. That’s according to a nonprofit ...

Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer put under the microscope. Cramer highlighted the importance of the company’s GLP-1 drug, as he stated: “I suggest, for example, that ...

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...

A combination of two cancer drugs may provide a pathway to treat Alzheimer’s, according to a study published July 21 in Cell. Researchers from the University of California San Francisco developed and ...